Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if HROW is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
32 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 58 days ago
Red flags: 0
223 filers reported a long position in HROW for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $116.4M | 2.7M | +7.3% |
| Opaleye Management Inc. | $101.9M | 2.4M | -15.3% |
| Private Capital Management, LLC | $67.9M | 1.6M | +2.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $60.2M | 1.4M | +1% |
| Deep Track Capital, LP | $41.2M | 969K | New |
| STATE STREET CORP | $39.9M | 939.9K | +9.9% |
| GEODE CAPITAL MANAGEMENT, LLC | $38.5M | 905.6K | +6.3% |
| BAMCO INC /NY/ | $34.4M | 809.4K | New |
| DIMENSIONAL FUND ADVISORS LP | $28.3M | 667K | +15.1% |
| Jupiter Topco LLC | $24.6M | 579.1K | — |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.